Single-center, open, randomized controlled trial about Chinese fasting therapy in the reversal of type 2 diabetes with overweight or obesity
- Conditions
- Type 2 Diabetes with Overweight or Obesity
- Registration Number
- ITMCTR2100004961
- Lead Sponsor
- The Seventh Affiliated Hospital of Sun Yat-sen University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- Not specified
1.Parient is aged 18 to 70 years;
2.According to the Chinese Guidelines of Type 2 Diabetes (2017 Edition), type 2 diabetes lasts within six years with overweight or obesity: 24kg/m^2 <= BMI <= 35kg/m^2;
3.Heart, liver, and kidney function is normal;
4.Signed the informed consent form.
All the above four items conformed can enter the group.
1.Patient has received insulin intensive therapy;
2.Pregnancy, lactation, or menstrual women;
3.Malignant tumor and hematonosis;
4.Patients with active tuberculosis;
5.Patients with ulcers with severe gastric bleeding;
6.Recently glylated hemoglobin >= 12%;
7.Other circumstances that investigators judging not suitable for inclusion.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method remission rate of blood sugar;
- Secondary Outcome Measures
Name Time Method weight loss range;